altimmune.com
Get leads like Altimmune — and thousands more
Build targeted lists by tech stack, traffic, and more
Altimmune: The $51M Peptide Play
A clinical-stage biotech betting big on obesity and liver disease therapeutics
In a market saturated with GLP-1 agonists, Altimmune is carving a distinct path by focusing on peptide-based therapeutics for obesity and liver disease. With $51.4M in funding and a clinical-stage pipeline, they're not just chasing trends—they're building the next generation of metabolic treatments.
"They're not just another biotech—they're a clinical-stage company with a clear focus on peptide therapeutics that address unmet needs in metabolic diseases."
The Growth Trajectory
Altimmune's website traffic tells an interesting story: 45% direct traffic indicates strong brand recognition among investors and industry players, while 42% organic search shows active interest in their pipeline. The fact that 'altimmune stock' is a top keyword reveals they're on the radar of retail and institutional investors alike.
Strategic Focus
Unlike many biotechs that spread resources thin, Altimmune has narrowed its focus to two critical areas: obesity and liver disease. Their lead candidate, pemvidutide, represents a targeted approach to peptide therapeutics. With CEO Vipin Garg at the helm and a lean team of 83, they're executing with precision.
The company's tech stack reveals a modern, efficient approach: Tailwind CSS and Bootstrap for rapid development, jQuery and Swiper for user experience, and dual analytics with Google Analytics and Matomo. They're building for speed and insight, not just presence.
- Clinical-stage company with focused pipeline in metabolic diseases
- Strong brand recognition evidenced by 45% direct traffic
- Peptide-based therapeutics approach for obesity and liver disease
- Experienced leadership team with Vipin Garg as CEO
- Active investor interest reflected in stock-related search volume
The Bottom Line
Altimmune represents a focused, clinical-stage bet on peptide therapeutics in metabolic diseases—backed by solid funding and clear strategic direction.
What tech stack does Altimmune use?
How much traffic does Altimmune get?
Traffic & Engagement
Traffic Sources
Where is Altimmune's audience located?
What keywords does Altimmune rank for?
5 keywordsHow is Altimmune's SEO?
Open Graph Image
https://altimmune.com/wp-content/uploads/2022/07/Facebook-OG.png
Meta Tags
Altimmune a clinical stage biopharmaceutical company
Altimmune a clinical stage biopharmaceutical company developing peptide-based therapeutics. Our focus is developing next generation peptide therapeutics for obesity and liver disease
H1 Tags
Schema Types
What is Altimmune's revenue?
Who competes with Altimmune?
Who works at Altimmune?
Loading leads...
What do customers think of Altimmune?
No Trustpilot reviews available for this company.
Frequently Asked Questions about Altimmune
What is Altimmune's Revenue?
What does Altimmune do?
How fast is Altimmune growing?
What technologies does Altimmune use?
Who are Altimmune's competitors?
Export Data
Unlock all exports
Download CSVs, JSONs & full reports
How to contact Altimmune?
Social Profiles
Contact Information
Export altimmune.com Data
Download the complete tech stack, analytics, leads, and company data for altimmune.com in JSON or CSV format. Use it for your sales pipeline, competitive analysis, or research.
Raw JSON Data
Click "Show" to view the raw API response data
About altimmune.com
Altimmune a clinical stage biopharmaceutical company developing peptide-based therapeutics. Our focus is developing next generation peptide therapeutics for obesity and liver disease
Company Overview
altimmune.com Social Media
Contact altimmune.com
Phone Numbers
Technology Stack
altimmune.com uses 18 technologies across their website including Font Awesome, Adobe Fonts, PHP, WordPress, and more.
Fonts
Font Awesome, Adobe Fonts, Google Fonts
Programming Languages
PHP
CMS
WordPress
E-commerce & Payments
WooCommerce
Analytics & Marketing
Matomo, Google Analytics
Performance
Priority Hints
Traffic & Audience
altimmune.com receives approximately 205.4K monthly visitors and ranks #314,225 globally. The website has a bounce rate of 19% with visitors viewing an average of 2.7 pages per visit. Users spend an average of 5:29 on the site.
The majority of altimmune.com's traffic comes from undefined, undefined, .
Frequently Asked Questions
What is altimmune.com?
What technologies does altimmune.com use?
How do I contact altimmune.com?
What are altimmune.com's social media accounts?
Is altimmune.com hiring?
How popular is altimmune.com?
Related Searches
This page provides publicly available information about altimmune.com. Data is collected from various public sources and may not always be up to date. For the most accurate information, please visit altimmune.com directly at https://altimmune.com.